Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-15
DOI
10.3389/fphys.2021.775029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study
- (2021) Pablo Molina et al. JOURNAL OF NEPHROLOGY
- Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study “Hephaestus”
- (2021) Francesco Pizzarelli et al. JOURNAL OF NEPHROLOGY
- Body composition, adipokines, FGF23-Klotho and bone in kidney transplantation: Is there a link?
- (2021) Anca Matei et al. JOURNAL OF NEPHROLOGY
- Two-Week Burden of Arrhythmias across CKD Severity in a Large Community-Based Cohort: The ARIC Study
- (2021) Esther D. Kim et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Strategies to lower fibroblast growth factor-23 bioactivity
- (2021) Devin Verbueken et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of a medium cut‐off dialyzer on protein‐bound uremic toxins and mineral metabolism markers in patients on hemodialysis
- (2021) Mark K. Tiong et al. Hemodialysis International
- Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)2D and normal FGF7 concentrations characterize patients with CKD
- (2021) Kittrawee Kritmetapak et al. BMC Nephrology
- The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease
- (2021) Yan Chen et al. International Journal of General Medicine
- The Protein-Independent Role of Phosphate in the Progression of Chronic Kidney Disease
- (2021) Irene Faria Duayer et al. Toxins
- Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
- (2021) Darius L. Mason et al. CTS-Clinical and Translational Science
- Hyperphosphatemia and Chronic Kidney Disease: A Major Daily Concern Both in Adults and in Children
- (2020) Justine Bacchetta et al. CALCIFIED TISSUE INTERNATIONAL
- The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis
- (2020) Hui-ling Hsieh et al. PLoS One
- Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure
- (2020) María Tamayo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture
- (2020) Jan M Hughes-Austin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
- (2020) Jonathan P. Law et al. Journal of the American Heart Association
- The Serum Concentration of Anti-Aging Proteins, Sirtuin1 and αKlotho in Patients with End-Stage Kidney Disease on Maintenance Hemodialysis
- (2020) Edyta Zbroch et al. Clinical Interventions in Aging
- Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial
- (2020) Xiang-Yang Liu et al. Annals of Translational Medicine
- Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
- (2020) Tally Naveh-Many et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure
- (2020) Ellen Neven et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardiovascular Consequences of Acute Kidney Injury
- (2020) Matthieu Legrand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease
- (2020) Syazrah Salam et al. BONE
- Enhanced Klotho availability protects against cardiac dysfunction induced by uraemic cardiomyopathy by regulating Ca 2+ handling
- (2020) José Alberto Navarro‐García et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)
- (2020) Nigel D. Toussaint et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans
- (2020) Bernhard Bielesz et al. Journal of Clinical Medicine
- FGF23 , Frailty, and Falls in SPRINT
- (2020) Anna Jovanovich et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
- (2019) Kenichiro Iio et al. Scientific Reports
- Metabolomics assessment reveals oxidative stress and altered energy production in the heart after ischemic acute kidney injury in mice
- (2019) Benjamin M. Fox et al. KIDNEY INTERNATIONAL
- Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial
- (2019) Barbara Ruggiero et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action
- (2019) Mona S. Calvo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
- (2019) Joachim H. Ix et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Key Role of Phosphate on Vascular Calcification
- (2019) Mario Cozzolino et al. Toxins
- Physical performance, plasma S-klotho, and all-cause mortality in elderly dialysis patients: A prospective cohort study
- (2019) Pedro L. Valenzuela et al. EXPERIMENTAL GERONTOLOGY
- Calcitriol and FGF-23, but neither PTH nor sclerostin, are associated with calciuria in CKD
- (2019) J. Ramalho et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Andrew A. House et al. KIDNEY INTERNATIONAL
- Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis
- (2019) Evangelos Memmos et al. BMC Nephrology
- Arrhythmias in Patients on Maintenance Dialysis: A Cross-sectional Study
- (2019) Jesper Moesgaard Rantanen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
- (2019) Ineke Böckmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients
- (2019) Yuichi Takashi et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function
- (2019) Linto Thomas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients
- (2019) Hongran Moon et al. BMC Nephrology
- Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
- (2019) Tamara Isakova et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients
- (2019) Kimihiko Nakamura et al. Clinical and Experimental Nephrology
- The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
- (2019) Caixia Yin et al. CLINICAL NEPHROLOGY
- Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study
- (2019) Maria E. Rodríguez-Ortiz et al. European Journal of Internal Medicine
- Highlight article: αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats
- (2019) Paulo Giovani de Albuquerque Suassuna et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials
- (2019) Christopher T. Chan et al. Hemodialysis International
- FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice
- (2019) Xiaobin Han et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
- (2019) Maarten A De Jong et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo
- (2018) Yue Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients
- (2018) David E. Leaf et al. Clinical Journal of the American Society of Nephrology
- Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events
- (2018) Alan S. Go et al. Clinical Journal of the American Society of Nephrology
- C-terminal and intact FGF23 in critical illness and their associations with acute kidney injury and in-hospital mortality
- (2018) Karolina Rygasiewicz et al. CYTOKINE
- PTH, vitamin D, and the FGF-23-klotho axis and heart: Going beyond the confines of nephrology
- (2018) José Alberto Navarro-García et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23
- (2018) Isao Matsui et al. KIDNEY INTERNATIONAL
- Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle
- (2018) Prabir Roy-Chaudhury et al. KIDNEY INTERNATIONAL
- Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
- (2018) Markus Ketteler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study
- (2018) L.-C. Desbiens et al. OSTEOPOROSIS INTERNATIONAL
- Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy
- (2018) Su-Young Jung et al. PLoS One
- Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients
- (2018) Monica Coll et al. PLoS One
- Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
- (2018) Maren Leifheit-Nestler et al. Frontiers in Endocrinology
- Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study
- (2018) Akiko Owaki et al. RENAL FAILURE
- The Klotho proteins in health and disease
- (2018) Makoto Kuro-o Nature Reviews Nephrology
- Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes
- (2018) José Alberto Navarro-García et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dysregulated Mineral Metabolism in AKI
- (2018) David E. Leaf et al. SEMINARS IN NEPHROLOGY
- Cardiorenal Syndrome in Acute Kidney Injury
- (2018) Luca Di Lullo et al. SEMINARS IN NEPHROLOGY
- The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
- (2018) Matthew J. Damasiewicz et al. BMC Nephrology
- Heart failure in patients with kidney disease
- (2017) Courtney Tuegel et al. HEART
- Longitudinal FGF23 Trajectories and Mortality in Patients with CKD
- (2017) Tamara Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study
- (2017) David A. Drew et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
- (2017) Marlies Antlanger et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy
- (2017) Ming Chang Hu et al. KIDNEY INTERNATIONAL
- Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
- (2017) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Klotho suppresses the inflammatory responses and ameliorates cardiac dysfunction in aging endotoxemic mice
- (2017) Haipeng Hui et al. Oncotarget
- Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease
- (2017) Nisha Bansal et al. JAMA Cardiology
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- Deficiency in the anti-aging gene Klotho promotes aortic valve fibrosis through AMPKα-mediated activation of RUNX2
- (2016) Jianglei Chen et al. AGING CELL
- Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder
- (2016) J Ruth Wu-Wong et al. BRITISH JOURNAL OF PHARMACOLOGY
- The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
- (2016) Alexander Grabner et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip
- (2016) Lars Lind et al. HEART
- Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease
- (2016) Jun Zou et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Sudden cardiac death in haemodialysis: clinical epidemiology and mechanisms
- (2016) Debasish Banerjee JOURNAL OF ELECTROCARDIOLOGY
- AKI and Long-Term Risk for Cardiovascular Events and Mortality
- (2016) Ayodele Odutayo et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Global cardiovascular protection in chronic kidney disease
- (2016) Gema Ruiz-Hurtado et al. Nature Reviews Cardiology
- Heart failure and kidney dysfunction: epidemiology, mechanisms and management
- (2016) Joerg C. Schefold et al. Nature Reviews Nephrology
- Klotho and S100A8/A9 as Discriminative Markers between Pre-Renal and Intrinsic Acute Kidney Injury
- (2016) Ae Jin Kim et al. PLoS One
- Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
- (2016) Rupal Mehta et al. JAMA Cardiology
- Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2015) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction
- (2015) Erin D. Unger et al. EUROPEAN JOURNAL OF HEART FAILURE
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
- (2015) Manfred Richter et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients
- (2015) Naoko Otani-Takei et al. International Journal of Endocrinology
- FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice
- (2015) Ningyuan Sun et al. Scientific Reports
- Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients
- (2015) Shahanas Chathoth et al. CardioRenal Medicine
- Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
- (2015) Kunihiro Matsushita et al. Lancet Diabetes & Endocrinology
- Uremic Retention Solute Indoxyl Sulfate Level Is Associated with Prolonged QTc Interval in Early CKD Patients
- (2015) Wei-Hua Tang et al. PLoS One
- Serum Phosphorus and Mortality in the Third National Health and Nutrition Examination Survey (NHANES III): Effect Modification by Fasting
- (2014) Alex R. Chang et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Niacin on FGF23 Concentration in Chronic Kidney Disease
- (2014) Madhumathi Rao et al. AMERICAN JOURNAL OF NEPHROLOGY
- Fibroblast Growth Factor-23 and Incident Atrial Fibrillation
- (2014) Jehu S. Mathew et al. CIRCULATION
- Elevated Parathyroid Hormone, But Not Vitamin D Deficiency, Is Associated With Increased Risk of Heart Failure in Older Men With and Without Cardiovascular Disease
- (2014) S. Goya Wannamethee et al. Circulation-Heart Failure
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
- (2014) Florence Lima et al. CLINICAL NEPHROLOGY
- FGF23 regulates renal sodium handling and blood pressure
- (2014) Olena Andrukhova et al. EMBO Molecular Medicine
- FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells
- (2014) Yu-Hsun Kao et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
- (2014) J. Xie et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Does cardiovascular protection translate into renal protection?
- (2014) Gema Ruiz-Hurtado et al. Nature Reviews Cardiology
- Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
- (2014) Julia J. Scialla et al. Nature Reviews Nephrology
- Plasma levels of fibroblast growth factor-23 are associated with muscle mass in haemodialysis patients
- (2014) Hirotaka Fukasawa et al. NEPHROLOGY
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
- (2014) G. S. Di Marco et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients
- (2014) Albina Nowak et al. PLoS One
- Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients
- (2014) Maurits S Buiten et al. BMC Nephrology
- Circulating α-Klotho Levels in CKD and Relationship to Progression
- (2013) Hyoung Rae Kim et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval
- (2013) Simonetta Genovesi et al. EUROPACE
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular Effects of Sevelamer in Stage 3 CKD
- (2013) C. D. Chue et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Plasma FGF23 levels increase rapidly after acute kidney injury
- (2013) Marta Christov et al. KIDNEY INTERNATIONAL
- Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification
- (2013) Jane L. Finch et al. KIDNEY INTERNATIONAL
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
- (2013) Ron T Gansevoort et al. LANCET
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
- (2012) Kenneth Lim et al. CIRCULATION
- Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome
- (2012) Israel Gotsman et al. EUROPEAN JOURNAL OF HEART FAILURE
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 removal is improved by on-line high-efficiency hemodiafiltration compared to conventional high flux hemodialysis
- (2012) Laure Patrier et al. JOURNAL OF NEPHROLOGY
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
- (2012) Johan Ärnlöv et al. KIDNEY INTERNATIONAL
- Role of renal Klotho in mineral metabolism
- (2012) Helene Myrvang Nature Reviews Nephrology
- Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial
- (2012) Mhairi Sigrist et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
- (2012) Jian Xie et al. Nature Communications
- Serum soluble ?-Klotho in hemodialysis patients
- (2011) Keitaro Yokoyama et al. CLINICAL NEPHROLOGY
- The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
- (2011) Sarah Seiler et al. EUROPEAN HEART JOURNAL
- Renal function and target organ damage in hypertension
- (2011) L. M. Ruilope et al. EUROPEAN HEART JOURNAL
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease
- (2011) Suetonia C. Palmer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Plasma Klotho and Mortality Risk in Older Community-Dwelling Adults
- (2011) R. D. Semba et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts
- (2011) Marije van der Velde et al. KIDNEY INTERNATIONAL
- Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population
- (2010) Jeffrey L. Anderson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects
- (2010) Yuji Yamazaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fibroblast Growth Factor 23 and Fetuin A are Independent Predictors for the Coronary Artery Disease Extent in Mild Chronic Kidney Disease
- (2010) M. Kanbay et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor-23 in Early Chronic Kidney Disease: Additional Support in Favor of a Phosphate-Centric Paradigm for the Pathogenesis of Secondary Hyperparathyroidism
- (2010) P. Evenepoel et al. Clinical Journal of the American Society of Nephrology
- Mechanisms involved in vitamin D mediated intestinal calcium absorption and in non-classical actions of vitamin D
- (2010) Sylvia Christakos et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
- (2010) M. Wolf JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
- (2010) M. C. Hu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Klotho and aging
- (2009) Makoto Kuro-o BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
- (2009) Claudio Ronco et al. EUROPEAN HEART JOURNAL
- Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism
- (2009) M. Curione et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
- (2009) Dinanda J. de Jager JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical relevance of FGF-23 in chronic kidney disease
- (2009) Sarah Seiler et al. KIDNEY INTERNATIONAL
- Current understanding of klotho
- (2008) Yuhong Wang et al. AGEING RESEARCH REVIEWS
- Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease
- (2008) Mervet Rouached et al. KIDNEY INTERNATIONAL
- The Klotho gene family as a regulator of endocrine fibroblast growth factors
- (2008) Hiroshi Kurosu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search